Harnal and liver disorder Patient Reports February 13, 2012

Harnal Side Effects Report #4608969-7
Harnal side effect was reported by a Consumer or non-health professional from on Feb 22, 2005. Male patient, 41 years of age, was diagnosed with spinocerebellar disorder and was treated with Harnal. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood bilirubin increased, blood lactate dehydrogenase increased, gamma-glutamyltransferase increased, liver disorder, lymphocyte stimulation test positive, malaise. Harnal dosage: 0.2 MG (NR) PO. During the same period patient was treated with DANTRIUM, LIORESAL, TERNELIN, VITAMEDIN, DIAZEPAM. Patient was hospitalized. Patient recovered.

Harnal Side Effects Report #5176585-7
Harnal side effect was reported by a Physician from JAPAN on Nov 13, 2006. Male patient, weighting 148.8 lb, was diagnosed with prostate cancer , benign prostatic hyperplasia and was treated with Harnal. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, liver disorder. Harnal dosage: unknown. During the same period patient was treated with LEUPLIN, ESTRACYT. Patient was hospitalized. Patient recovered.

Harnal Side Effects Report #5188888-0
Harnal side effect was reported by a Physician from JAPAN on Nov 13, 2006. Male patient, weighting 148.8 lb, was diagnosed with prostate cancer , benign prostatic hyperplasia and was treated with Harnal. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, liver disorder. Harnal dosage: unknown. During the same period patient was treated with LEUPROLIDE ACETATE, ESTRACYT. Patient was hospitalized. Patient recovered.

Harnal Side Effects Report #4920080-4
Harnal side effect was reported by a Physician from JAPAN on Feb 14, 2006. Male patient, 84 years of age, was diagnosed with benign prostatic hyperplasia and was treated with Harnal. After drug was administered, patient experienced the following side effects: liver disorder, renal disorder. Harnal dosage: unknown. During the same period patient was treated with DANTRIUM, ACECOL. Patient was hospitalized. Patient recovered.


Harnal Side Effects Report #4929479-3
Harnal side effect was reported by a Physician from JAPAN on Feb 14, 2006. Male patient, 84 years of age, was diagnosed with benign prostatic hyperplasia and was treated with Harnal. After drug was administered, patient experienced the following side effects: liver disorder, renal disorder. Harnal dosage: unknown. During the same period patient was treated with DANTRIUM, ACECOL. Patient was hospitalized. Patient recovered.

Harnal Side Effects Report #4579616-8
Harnal side effect was reported by a Consumer or non-health professional from on Jan 26, 2005. Male patient, 69 years of age, was diagnosed with benign prostatic hyperplasia, haemorrhoids, rectal prolapse and was treated with Harnal. After drug was administered, patient experienced the following side effects: haemorrhoids, hepatocellular damage, jaundice , liver disorder. Harnal dosage: 0.2 MG (0.2 MG QD) , PO. During the same period patient was treated with LECORUC, TAKAVENSU. Patient was hospitalized. Patient recovered.

Harnal Side Effects Report #5152559-7
Harnal side effect was reported by a Physician from JAPAN on Nov 13, 2006. Male patient, 59 years of age, was diagnosed with benign prostatic hyperplasia and was treated with Harnal. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, liver disorder. Harnal dosage: unknown. During the same period patient was treated with ESTRACYT, LEUPLIN. Patient was hospitalized. Patient recovered.

Harnal Side Effects Report #5575392-0
Harnal side effect was reported by a Physician from JAPAN on Dec 20, 2007. Male patient, weighting 145.5 lb, was diagnosed with benign prostatic hyperplasia, cerebral infarction, hypertension, constipation , diabetes mellitus and was treated with Harnal. After drug was administered, patient experienced the following side effects: biliary tract disorder, liver disorder. Harnal dosage: unknown. During the same period patient was treated with BUFFERIN, RENIVEZE, OZAGREL, SENNOSIDE, CETILO, INSULINECTION. Patient was hospitalized. Patient recovered.